Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
40.4M
-
Shares change
-
+639K
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$2.22M
-
Number of buys
-
29
-
Number of sells
-
-33
-
Price
-
$4.58
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q3 2023
72 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q3 2023.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.4M shares
of 130M outstanding shares and own 31.13% of the company stock.
Largest 10 shareholders include Social Capital Group LLC (11.6M shares), MORGAN STANLEY (10.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.87M shares), VANGUARD GROUP INC (3.29M shares), BlackRock Inc. (2.81M shares), Bleichroeder LP (2M shares), BANK OF AMERICA CORP /DE/ (1.42M shares), Brown University (1M shares), STATE STREET CORP (908K shares), and GEODE CAPITAL MANAGEMENT, LLC (828K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.